UP­DAT­ED Dew­point nabs ex-Sanofi CEO Brandi­court and Bay­er VC chief Eck­hardt for board

Bay­er-part­nered Dew­point Ther­a­peu­tics is adding a pair of big-name phar­ma vets as it looks to make drugs tar­get­ing bio­mol­e­c­u­lar con­den­sates a re­al­i­ty.

The Boston biotech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER